Healthcare-associated infections (HAIs), previously known as nosocomial infections, represent a significant threat to healthcare systems worldwide, prolonging patient hospital stays and the duration of antimicrobial therapy. One of the most serious consequences of HAIs is the increase in the rate of antibiotic resistance (AR) generated by the prolonged, frequent, and sometimes incorrect use of antibiotics, which leads to the selection of resistant bacteria, making treatment difficult and expensive, with direct consequences for the safety of patients and healthcare personnel. Therefore, timely and accurate diagnosis of HAIs is mandatory to develop appropriate infection prevention and control practices (IPC) and new therapeutic strategies. This review aimed to present the prevalence, risk factors, current diagnosis, including artificial intelligence (AI) and machine learning approaches, future perspectives in combating HAIs causative bacteria (phage therapy, microbiome-based interventions, and vaccination), and HAIs surveillance strategies. Also, we discussed the latest findings regarding the relationships of AR with climate change and environmental pollution in the context of the One Health approach. Phage therapy is an emerging option that can offer an alternative to ineffective antibiotic treatments for antibiotic-resistant bacteria causing HAIs. Clinical trials dealing with vaccine development for resistant bacteria have yielded conflicting results. Two promising strategies, fecal microbiota transplantation and probiotic therapy, proved highly effective against recurrent Clostridium difficile infections and have been shown to reduce HAI incidence in hospitalized patients undergoing antibiotic therapy. Artificial intelligence and machine learning systems offer promising predictive capabilities in processing large volumes of clinical, microbiological, and patient data but require robust data integration. Our paper argues that HAIs are still a global challenge, requiring stringent IPC policies, computer vision, and AI-powered tools. Despite promising avenues like integrated One Health approaches, optimized phage therapy, microbiome-based interventions, and targeted vaccine development, several knowledge gaps in clinical efficacy, standardization, and pathogen complexity remain to be answered.

For full checkpoint on a large-scale HPC system, huge memory contexts must potentially be transferred through the network and saved in a reliable storage. As such, the time taken to checkpoint becomes a critical issue which directly impacts the total execution time. Therefore, incremental checkpoint as a less intrusive method to reduce the waste time has been gaining significant attentions in the HPC community. In this paper, we built a model that aims to reduce full checkpoint overhead by performing a set of incremental checkpoints between two consecutive full checkpoints. Moreover, a method to find the number of those incremental checkpoints is given. Furthermore, most of the comparison results between the incremental checkpoint model and the full checkpoint model (Liu et al., 2007) on the same failure data set show that the total waste time in the incremental checkpoint model is significantly smaller than the waste time in the full checkpoint model.

To better understand the potential of drug repurposing in COVID-19, we analyzed control strategies over essential host factors for SARS-CoV-2 infection. We constructed comprehensive directed protein–protein interaction (PPI) networks integrating the top-ranked host factors, the drug target proteins and directed PPI data. We analyzed the networks to identify drug targets and combinations thereof that offer efficient control over the host factors. We validated our findings against clinical studies data and bioinformatics studies. Our method offers a new insight into the molecular details of the disease and into potentially new therapy targets for it. Our approach for drug repurposing is significant beyond COVID-19 and may be applied also to other diseases.

The increase in the physical size of high performance computing (HPC) platform makes system reliability more challenging. In order to minimize the performance loss (rollback and checkpoint overheads) due to unexpected failures or unnecessary overhead of fault tolerant mechanisms, we present a reliability-aware method for an optimal checkpoint/restart strategy. Our scheme aims at addressing fault tolerance challenge, especially in a large-scale HPC system, by providing optimal checkpoint placement techniques that are derived from the actual system reliability. Unlike existing checkpoint models, which can only handle Poisson failure and a constant checkpoint interval, our model can deal with a varying checkpoint interval and with different failure distributions. In addition, the approach considers optimality for both checkpoint overhead and rollback time. Our validation results suggest a significant improvement over existing techniques.

Since the discovery of lanthanides, the expanding range of applications and the growing demand for lanthanides in different aspects of life have escalated their dispersion in the environment, raising concerns about their impact on the living world. This review explores the interaction between lanthanides and different groups of living organisms (bacteria, algae, lichens, plants, invertebrates, and low vertebrates), reflecting the current state of scientific knowledge. We have aimed to provide a comprehensive overview of relevant studies, highlight existing gaps, and suggest potential areas for future research to enhance the understanding of this topic.

Reliability estimation of High Performance Computing (HPC) systems enables resource allocation, and fault tolerance frameworks to minimize the performance loss due to unexpected failures. Recent studies have shown that compute nodes in HPC systems follow a time varying failure rate distribution such as Weibull, instead of the exponential distribution. In this paper, we propose a model for the Time to Failure (TTF) distribution of a system of k s-independent nodes when individual nodes exhibit time varying failure rates. We also present the system reliability, failure rates, Mean Time to Failure (MTTF), and derivations of the proposed system TTF model. The model is validated using observed data on time to failure.